Synergy of amlodipine and angiotensin-converting enzyme inhibitors in regulating myocardial oxygen consumption in normal canine and failing human hearts

Seema Mital, Kit E. Loke, James Slater, Linda Addonizio, Welton M. Gersony, Thomas H. Hintze

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The production of endogenous nitric oxide, which regulates myocardial oxygen consumption, is decreased in heart failure. As with angiotensin- converting enzyme (ACE) inhibitors, amlodipine, a calcium antagonist, increases kinin-mediated nitric oxide production in coronary microvessels. We investigated the possibility of synergy between ACE inhibitors and amlodipine in regulating myocardial oxygen consumption. Left ventricular myocardium was isolated from 6 healthy dog hearts and 5 human hearts with end-stage heart failure at the time of orthotopic heart transplantation. Myocardial oxygen consumption was measured before and after administration of bradykinin, S- nitroso N-acetyl penicillamine (SNAP, a nitric oxide donor), ramiprilat (an ACE inhibitor), amlodipine, and the combination of a subthreshold dose of ramiprilat (10-8 mol/L) + amlodipine. These experiments were repeated with L-nitro-arginine methyl ester (L-NAME, an inhibitor of nitric oxide synthesis), dichloroisocoumarin (an inhibitor of kinin synthesis), and HOE 140 (a B2 kinin-receptor antagonist). Baseline myocardial oxygen consumption in canine hearts was 182 ± 21 nmol/g/min. Bradykinin and SNAP caused dose- dependent reductions in myocardial oxygen consumption (p <0.05). Ramiprilat and amlodipine caused a 10 ± 3.2% and 11 ± 0.8% reduction in myocardial oxygen consumption, respectively, when used alone (p < 0.05). In the presence of a subthreshold dose of ramiprilat, amlodipine caused a larger (15 ± 1.7%) reduction in myocardial oxygen consumption compared with either drug used alone (p <0.05). In human hearts, baseline myocardial oxygen consumption was 248 ± 57 nmol/g/min. Amlodipine caused a larger reduction in myocardial oxygen consumption when used with ramiprilat (22 ± 3.2%) as compared with amlodipine alone (15 ± 2.6%). The effect of both drugs was attenuated by L- NAME, dichloroisocoumarin, and HOE 140 (p <0.05). In conclusion, ACE inhibitors and amlodipine act synergistically to regulate myocardial oxygen consumption by modulating kinin-mediated nitric oxide release, and this combination of drugs may be useful in the treatment of heart failure.

Original languageEnglish (US)
Pages (from-to)92-98
Number of pages7
JournalAmerican Journal of Cardiology
Volume83
Issue number12 A
DOIs
StatePublished - Jun 17 1999
Externally publishedYes

Fingerprint

Amlodipine
Angiotensin-Converting Enzyme Inhibitors
Oxygen Consumption
Canidae
Kinins
Nitric Oxide
Heart Failure
NG-Nitroarginine Methyl Ester
Bradykinin
Penicillamine
Nitric Oxide Donors
Drug Combinations
Heart Transplantation
Microvessels
Treatment Failure
Pharmaceutical Preparations
Myocardium
ramiprilat
Dogs
Calcium

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Mital, Seema ; Loke, Kit E. ; Slater, James ; Addonizio, Linda ; Gersony, Welton M. ; Hintze, Thomas H. / Synergy of amlodipine and angiotensin-converting enzyme inhibitors in regulating myocardial oxygen consumption in normal canine and failing human hearts. In: American Journal of Cardiology. 1999 ; Vol. 83, No. 12 A. pp. 92-98.
@article{047cd734d9f1412080733cecfa89b58e,
title = "Synergy of amlodipine and angiotensin-converting enzyme inhibitors in regulating myocardial oxygen consumption in normal canine and failing human hearts",
abstract = "The production of endogenous nitric oxide, which regulates myocardial oxygen consumption, is decreased in heart failure. As with angiotensin- converting enzyme (ACE) inhibitors, amlodipine, a calcium antagonist, increases kinin-mediated nitric oxide production in coronary microvessels. We investigated the possibility of synergy between ACE inhibitors and amlodipine in regulating myocardial oxygen consumption. Left ventricular myocardium was isolated from 6 healthy dog hearts and 5 human hearts with end-stage heart failure at the time of orthotopic heart transplantation. Myocardial oxygen consumption was measured before and after administration of bradykinin, S- nitroso N-acetyl penicillamine (SNAP, a nitric oxide donor), ramiprilat (an ACE inhibitor), amlodipine, and the combination of a subthreshold dose of ramiprilat (10-8 mol/L) + amlodipine. These experiments were repeated with L-nitro-arginine methyl ester (L-NAME, an inhibitor of nitric oxide synthesis), dichloroisocoumarin (an inhibitor of kinin synthesis), and HOE 140 (a B2 kinin-receptor antagonist). Baseline myocardial oxygen consumption in canine hearts was 182 ± 21 nmol/g/min. Bradykinin and SNAP caused dose- dependent reductions in myocardial oxygen consumption (p <0.05). Ramiprilat and amlodipine caused a 10 ± 3.2{\%} and 11 ± 0.8{\%} reduction in myocardial oxygen consumption, respectively, when used alone (p < 0.05). In the presence of a subthreshold dose of ramiprilat, amlodipine caused a larger (15 ± 1.7{\%}) reduction in myocardial oxygen consumption compared with either drug used alone (p <0.05). In human hearts, baseline myocardial oxygen consumption was 248 ± 57 nmol/g/min. Amlodipine caused a larger reduction in myocardial oxygen consumption when used with ramiprilat (22 ± 3.2{\%}) as compared with amlodipine alone (15 ± 2.6{\%}). The effect of both drugs was attenuated by L- NAME, dichloroisocoumarin, and HOE 140 (p <0.05). In conclusion, ACE inhibitors and amlodipine act synergistically to regulate myocardial oxygen consumption by modulating kinin-mediated nitric oxide release, and this combination of drugs may be useful in the treatment of heart failure.",
author = "Seema Mital and Loke, {Kit E.} and James Slater and Linda Addonizio and Gersony, {Welton M.} and Hintze, {Thomas H.}",
year = "1999",
month = "6",
day = "17",
doi = "10.1016/S0002-9149(99)00269-6",
language = "English (US)",
volume = "83",
pages = "92--98",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "12 A",

}

Synergy of amlodipine and angiotensin-converting enzyme inhibitors in regulating myocardial oxygen consumption in normal canine and failing human hearts. / Mital, Seema; Loke, Kit E.; Slater, James; Addonizio, Linda; Gersony, Welton M.; Hintze, Thomas H.

In: American Journal of Cardiology, Vol. 83, No. 12 A, 17.06.1999, p. 92-98.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Synergy of amlodipine and angiotensin-converting enzyme inhibitors in regulating myocardial oxygen consumption in normal canine and failing human hearts

AU - Mital, Seema

AU - Loke, Kit E.

AU - Slater, James

AU - Addonizio, Linda

AU - Gersony, Welton M.

AU - Hintze, Thomas H.

PY - 1999/6/17

Y1 - 1999/6/17

N2 - The production of endogenous nitric oxide, which regulates myocardial oxygen consumption, is decreased in heart failure. As with angiotensin- converting enzyme (ACE) inhibitors, amlodipine, a calcium antagonist, increases kinin-mediated nitric oxide production in coronary microvessels. We investigated the possibility of synergy between ACE inhibitors and amlodipine in regulating myocardial oxygen consumption. Left ventricular myocardium was isolated from 6 healthy dog hearts and 5 human hearts with end-stage heart failure at the time of orthotopic heart transplantation. Myocardial oxygen consumption was measured before and after administration of bradykinin, S- nitroso N-acetyl penicillamine (SNAP, a nitric oxide donor), ramiprilat (an ACE inhibitor), amlodipine, and the combination of a subthreshold dose of ramiprilat (10-8 mol/L) + amlodipine. These experiments were repeated with L-nitro-arginine methyl ester (L-NAME, an inhibitor of nitric oxide synthesis), dichloroisocoumarin (an inhibitor of kinin synthesis), and HOE 140 (a B2 kinin-receptor antagonist). Baseline myocardial oxygen consumption in canine hearts was 182 ± 21 nmol/g/min. Bradykinin and SNAP caused dose- dependent reductions in myocardial oxygen consumption (p <0.05). Ramiprilat and amlodipine caused a 10 ± 3.2% and 11 ± 0.8% reduction in myocardial oxygen consumption, respectively, when used alone (p < 0.05). In the presence of a subthreshold dose of ramiprilat, amlodipine caused a larger (15 ± 1.7%) reduction in myocardial oxygen consumption compared with either drug used alone (p <0.05). In human hearts, baseline myocardial oxygen consumption was 248 ± 57 nmol/g/min. Amlodipine caused a larger reduction in myocardial oxygen consumption when used with ramiprilat (22 ± 3.2%) as compared with amlodipine alone (15 ± 2.6%). The effect of both drugs was attenuated by L- NAME, dichloroisocoumarin, and HOE 140 (p <0.05). In conclusion, ACE inhibitors and amlodipine act synergistically to regulate myocardial oxygen consumption by modulating kinin-mediated nitric oxide release, and this combination of drugs may be useful in the treatment of heart failure.

AB - The production of endogenous nitric oxide, which regulates myocardial oxygen consumption, is decreased in heart failure. As with angiotensin- converting enzyme (ACE) inhibitors, amlodipine, a calcium antagonist, increases kinin-mediated nitric oxide production in coronary microvessels. We investigated the possibility of synergy between ACE inhibitors and amlodipine in regulating myocardial oxygen consumption. Left ventricular myocardium was isolated from 6 healthy dog hearts and 5 human hearts with end-stage heart failure at the time of orthotopic heart transplantation. Myocardial oxygen consumption was measured before and after administration of bradykinin, S- nitroso N-acetyl penicillamine (SNAP, a nitric oxide donor), ramiprilat (an ACE inhibitor), amlodipine, and the combination of a subthreshold dose of ramiprilat (10-8 mol/L) + amlodipine. These experiments were repeated with L-nitro-arginine methyl ester (L-NAME, an inhibitor of nitric oxide synthesis), dichloroisocoumarin (an inhibitor of kinin synthesis), and HOE 140 (a B2 kinin-receptor antagonist). Baseline myocardial oxygen consumption in canine hearts was 182 ± 21 nmol/g/min. Bradykinin and SNAP caused dose- dependent reductions in myocardial oxygen consumption (p <0.05). Ramiprilat and amlodipine caused a 10 ± 3.2% and 11 ± 0.8% reduction in myocardial oxygen consumption, respectively, when used alone (p < 0.05). In the presence of a subthreshold dose of ramiprilat, amlodipine caused a larger (15 ± 1.7%) reduction in myocardial oxygen consumption compared with either drug used alone (p <0.05). In human hearts, baseline myocardial oxygen consumption was 248 ± 57 nmol/g/min. Amlodipine caused a larger reduction in myocardial oxygen consumption when used with ramiprilat (22 ± 3.2%) as compared with amlodipine alone (15 ± 2.6%). The effect of both drugs was attenuated by L- NAME, dichloroisocoumarin, and HOE 140 (p <0.05). In conclusion, ACE inhibitors and amlodipine act synergistically to regulate myocardial oxygen consumption by modulating kinin-mediated nitric oxide release, and this combination of drugs may be useful in the treatment of heart failure.

UR - http://www.scopus.com/inward/record.url?scp=0033577955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033577955&partnerID=8YFLogxK

U2 - 10.1016/S0002-9149(99)00269-6

DO - 10.1016/S0002-9149(99)00269-6

M3 - Article

C2 - 10750596

AN - SCOPUS:0033577955

VL - 83

SP - 92

EP - 98

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 12 A

ER -